Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Covaris Introduces Bench-top, AFA-based Process Technology

March 25, 2011 By Bio-Medicine.Org

WOBURN, Mass., March 25, 2011 /PRNewswire/ — Covaris
Incorporated today announced the introduction of the Bench-top
SF220
High Performance Formulation Processing System.

The SF220 system was designed to extend the company’s
ground-breaking Adaptive Focused Acoustics (AFA) technology to
higher volume sample processing.  With the ability to process
sample volumes from microliters through tens of liters, larger
volume application areas such as Pre-clinical formulation, drug
delivery systems, and biological processes (such as cell lysis,
sonoporation, or transfection) can now “scale-up” the advantages of
the proven AFA technology.

The Covaris SF220 system provides a solution for the problem of
poorly soluble API’s using the proprietary Covaris AFA Technology.
 For example, adoption of the AFA-based SF220 system for
preparation of DMPK formulations has been shown to improve quality
of the studies by increasing the bioavailability, while reducing
subjective content and improving operational efficiency.
 Using AFA to accelerate dissolution can improve both the
quality and efficiency of the drug development process, with
unparalleled reproducibility, precision, and speed.
 Demonstrated increases of solubility of over 90% have been
achieved, while concurrently reducing the process time from over 2
days of stirring to under 3 minutes, and increasing the available
API by over 2.5x due to a dramatic reduction in API degradation.
  According to Jim Laugharn, Founder and CEO, “We at Covaris
are very excited about the introduction of the new systems to meet
the ‘pent-up demand’ our current customers have for processing
larger sample volumes with AFA technology.”  At present,
Covaris has installed over 1,500 systems in over 30 countries
worldwide.

AFA has also been demonstrated to formulate monodisperse,
nano-emulsions with mean particle sizes of 20nm and an index below
0.100.  Liposomes can be produced using a simp

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech